Gene PilotLX for Cancer
Trial Summary
What is the purpose of this trial?
This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four cancer centers.
Do I need to stop my current medications for the Gene PilotLX trial?
The trial information does not specify whether you need to stop taking your current medications.
What safety data exists for Gene PilotLX or similar treatments?
The safety data for ALK inhibitors, which are similar to Gene PilotLX, show that they generally have a favorable safety profile with most side effects being mild to moderate. Common side effects can often be managed by adjusting the dose, and no new safety concerns have been observed in long-term studies.12345
How does the treatment Gene PilotLX differ from other cancer treatments?
Research Team
Sarah B Bass, PhD, MPH
Principal Investigator
Temple University
Tracey A Revenson, PhD
Principal Investigator
Hunter College of City University of New York
Michael J. Hall
Principal Investigator
Fox Chase Cancer Center
Eligibility Criteria
This trial is for Latinx cancer patients who are interested in making informed decisions about their hereditary risks based on tumor genomic profiling tests. Participants will be recruited from four cancer centers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are randomized to either the Gene PilotLX tool or a TGP brochure to aid in decision-making about tumor genomic profiling.
Follow-up
Participants complete assessments to evaluate the efficacy of the intervention, including communication of preferences and decisional conflict.
Treatment Details
Interventions
- Gene PilotLX
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fox Chase Cancer Center
Lead Sponsor
Columbia University
Collaborator
Temple University
Collaborator
National Cancer Institute (NCI)
Collaborator
Herbert Irving Comprehensive Cancer Center
Collaborator
MD Anderson Cancer Center at Cooper
Collaborator
National Institutes of Health (NIH)
Collaborator